Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 370

1.

Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency.

Desar IM, Keuter M, Raemaekers JM, Jansen JB, van Krieken JH, van der Meer JW.

Neth J Med. 2006 May;64(5):136-40.

2.

Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.

Chen LT, Lin JT, Tai JJ, Chen GH, Yeh HZ, Yang SS, Wang HP, Kuo SH, Sheu BS, Jan CM, Wang WM, Wang TE, Wu CW, Chen CL, Su IJ, Whang-Peng J, Cheng AL.

J Natl Cancer Inst. 2005 Sep 21;97(18):1345-53.

PMID:
16174856
3.

A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.

Hong SS, Jung HY, Choi KD, Song HJ, Lee GH, Oh TH, Jo JY, Kim KJ, Byeon JS, Myung SJ, Yang SK, Hong WS, Kim JH, Min YI.

Helicobacter. 2006 Dec;11(6):569-73.

PMID:
17083379
4.

Characteristics of magnified endoscopic images of gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue, including changes after treatment.

Ono S, Kato M, Ono Y, Itoh T, Kubota K, Nakagawa M, Shimizu Y, Asaka M.

Gastrointest Endosc. 2008 Oct;68(4):624-31. doi: 10.1016/j.gie.2008.02.066. Epub 2008 Jun 5.

PMID:
18534580
5.

Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.

Komoto M, Tominaga K, Nakata B, Takashima T, Inoue T, Hirakawa K.

J Exp Clin Cancer Res. 2006 Jun;25(2):283-5.

PMID:
16918142
6.

Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight.

Santacroce L, Cagiano R, Del Prete R, Bottalico L, Sabatini R, Carlaio RG, Prejbeanu R, Vermesan H, Dragulescu SI, Vermesan D, Motoc A, Losacco T.

Clin Ter. 2008 Nov-Dec;159(6):457-62. Review.

PMID:
19169609
7.

Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.

Sumida T, Kitadai Y, Hiyama T, Shinagawa K, Tanaka M, Kodama M, Masuda H, Ito M, Tanaka S, Yoshihara M, Chayama K.

Cancer Sci. 2009 Jun;100(6):1075-81. doi: 10.1111/j.1349-7006.2009.01139.x. Epub 2009 Mar 25.

8.

Marginal zone lymphoma.

Shaye OS, Levine AM.

J Natl Compr Canc Netw. 2006 Mar;4(3):311-8. Review.

PMID:
16507274
9.

Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori: scratch and win.

Franco M, Rugge M, D'Andrea E, Mescoli C, Menin C, Farinati F.

Scand J Gastroenterol. 2005 Jan;40(1):115-9.

PMID:
15841725
10.

BCL10 nuclear expression and t(11;18)(q21;q21) indicate nonresponsiveness to Helicobacter pylori eradication of Chinese primary gastric MALT lymphoma.

Dong G, Liu C, Ye H, Gong L, Zheng J, Li M, Huang X, Huang X, Huang Y, Shi Y, Yin W, Gao Z.

Int J Hematol. 2008 Dec;88(5):516-23. doi: 10.1007/s12185-008-0187-z. Epub 2008 Oct 24.

PMID:
18949449
11.

Successful treatment of Helicobacter pylori-negative gastric MALT lymphoma with rituximab.

Chaudhary N, Ozer H, Huard D, Lightfoot S, Mesiya S.

Dig Dis Sci. 2006 Apr;51(4):775-8.

PMID:
16615002
12.

Long-term follow-up of gastric MALT lymphoma after H. pylori eradication.

Morgner A, Thiede C, Bayerdörffer E, Alpen B, Wündisch T, Neubauer A, Stolte M.

Curr Gastroenterol Rep. 2001 Dec;3(6):516-22. Review.

PMID:
11696290
13.

[Definitive treatment of Helicobacter pylori infection in MALT low degree gastric lymphoma].

Olmos Martínez JM, Cruz Vicente JM, Fernández Fernández F, González Macías J.

Rev Clin Esp. 2003 Dec;203(12):615-6. Spanish. No abstract available.

PMID:
14622518
14.

Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment.

Nakamura S, Matsumoto T, Ye H, Nakamura S, Suekane H, Matsumoto H, Yao T, Tsuneyoshi M, Du MQ, Iida M.

Cancer. 2006 Dec 15;107(12):2770-8.

15.

[Gastric MALT lymphoma, clinical features].

Udvardy M.

Orv Hetil. 1999 Feb 7;140(6):291-4. Hungarian.

PMID:
10071508
16.

[The gastric MALT lymphoma. An unforeseen model for studying the pathogenesis of the lymphomas].

Savio A.

Recenti Prog Med. 2009 Jun;100(6):311-21. Review. Italian.

PMID:
19708303
17.

Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.

Nakamura T, Seto M, Tajika M, Kawai H, Yokoi T, Yatabe Y, Nakamura S.

Am J Gastroenterol. 2008 Jan;103(1):62-70. Epub 2007 Sep 25.

PMID:
17894851
18.

Mucosa-associated lymphoid tissue-type lymphomas occurring in post-transplantation patients.

Hsi ED, Singleton TP, Swinnen L, Dunphy CH, Alkan S.

Am J Surg Pathol. 2000 Jan;24(1):100-6.

PMID:
10632493
19.

The possible involvement of micro-organisms other than Helicobacter pylori in the development of rectal MALT lymphoma in H. pylori-negative patients.

Nakase H, Okazaki K, Ohana M, Ikeda K, Uchida K, Uose S, Itoh T, Iwano M, Watanabe N, Yazumi S, Kawanami C, Inoue F, Chiba T.

Endoscopy. 2002 Apr;34(4):343-6.

PMID:
11932795
20.

Helicobacter heilmannii infection: clinical, endoscopic and histopathological features in Japanese patients.

Okiyama Y, Matsuzawa K, Hidaka E, Sano K, Akamatsu T, Ota H.

Pathol Int. 2005 Jul;55(7):398-404.

PMID:
15982214

Supplemental Content

Support Center